Chris Starling

590 total citations
5 papers, 300 citations indexed

About

Chris Starling is a scholar working on Molecular Biology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Chris Starling has authored 5 papers receiving a total of 300 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Molecular Biology, 1 paper in Surgery and 1 paper in Pulmonary and Respiratory Medicine. Recurrent topics in Chris Starling's work include RNA modifications and cancer (1 paper), Pharmacological Effects of Natural Compounds (1 paper) and Liver physiology and pathology (1 paper). Chris Starling is often cited by papers focused on RNA modifications and cancer (1 paper), Pharmacological Effects of Natural Compounds (1 paper) and Liver physiology and pathology (1 paper). Chris Starling collaborates with scholars based in United Kingdom, United States and Canada. Chris Starling's co-authors include Bart Wagner, Leonie S. Taams, Mark McPhail, Diego Vergani, R.D. Abeles, Sabine Pomplun, William Bernal, Nigel Heaton, Ragai R. Mitry and Alberto Quaglia and has published in prestigious journals such as Hepatology, Cancer Research and Journal of Hepatology.

In The Last Decade

Chris Starling

4 papers receiving 299 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Chris Starling United Kingdom	3	144	117	77	70	68	5	300
Jo Suda United States	9	69 0.5×	106 0.9×	116 1.5×	63 0.9×	48 0.7×	11	351
Kenichi Okano Japan	11	152 1.1×	41 0.4×	126 1.6×	46 0.7×	66 1.0×	24	341
Ruidong Mo China	9	179 1.2×	67 0.6×	263 3.4×	84 1.2×	32 0.5×	15	392
Jayashree Bagchi Chakraborty United Kingdom	5	120 0.8×	42 0.4×	153 2.0×	111 1.6×	25 0.4×	5	328
Kiyoshi Nishiyama Japan	10	105 0.7×	33 0.3×	116 1.5×	121 1.7×	82 1.2×	20	374
Sibille Sauer-Lehnen Germany	6	317 2.2×	58 0.5×	265 3.4×	32 0.5×	98 1.4×	6	497
Dongying Xue China	11	141 1.0×	63 0.5×	148 1.9×	25 0.4×	30 0.4×	26	331
Giacomo Batignani Italy	2	183 1.3×	37 0.3×	233 3.0×	25 0.4×	57 0.8×	5	357
G. Marquitan Germany	10	122 0.8×	29 0.2×	207 2.7×	80 1.1×	27 0.4×	12	386
P Georgiev Switzerland	6	158 1.1×	32 0.3×	134 1.7×	19 0.3×	75 1.1×	7	382

Countries citing papers authored by Chris Starling

Since Specialization

Citations

This map shows the geographic impact of Chris Starling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chris Starling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chris Starling more than expected).

Fields of papers citing papers by Chris Starling

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chris Starling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chris Starling. The network helps show where Chris Starling may publish in the future.

Co-authorship network of co-authors of Chris Starling

This figure shows the co-authorship network connecting the top 25 collaborators of Chris Starling. A scholar is included among the top collaborators of Chris Starling based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chris Starling. Chris Starling is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

5 of 5 papers shown

1.

Zhang, Yu, Ioanna Mavrommati, Chris Starling, et al.. (2024). Abstract PO4-13-11: Epigenetically defined sub-clonal heterogeneity drives therapy resistance in triple-negative breast cancer. Cancer Research. 84(9_Supplement). PO4–13. 1 indexed citations

2.

Zhang, Yu, et al.. (2024). Abstract B059: Epigenetically defined sub-clonal heterogeneity drives therapy resistance in triple-negative breast cancer. Cancer Research. 84(3_Supplement_1). B059–B059.

3.

Turrell, Frances K., Naomi Guppy, Andrea Gillespie, et al.. (2023). Age-associated microenvironmental changes highlight the role of PDGF-C in ER+ breast cancer metastatic relapse. Nature Cancer. 4(4). 468–484. 44 indexed citations

4.

Grammatikopoulos, Tassos, Melissa Sambrotta, Sandra Strautnieks, et al.. (2016). Mutations in DCDC2 (doublecortin domain containing protein 2) in neonatal sclerosing cholangitis. Journal of Hepatology. 65(6). 1179–1187. 47 indexed citations

5.

Antoniades, Charalambos G., Alberto Quaglia, Leonie S. Taams, et al.. (2012). Source and characterization of hepatic macrophages in acetaminophen-induced acute liver failure in humans. Hepatology. 56(2). 735–746. 208 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact